Delivery Order SPE2DB25D3404-SPE2DB25FUNRE
Award Date 6/2/25
Potential Completion Date 6/24/25
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $21,325.14 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order was issued on July 22, 2025, with an ultimate completion date of August 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters and primary distribution center. Tagrisso (osimertinib) is an advanced...
- The Defense Logistics Agency awarded a $10,641.07 delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Tagrisso 40 mg tablets, with an ultimate completion date of June 2, 2025. This is a firm fixed-price, non-set-aside contract awarded on May 9, 2025, with performance at the company's Conshohocken, Pennsylvania facility. Tagrisso (osimertinib) is a targeted cancer therapy used primarily in treating non-small cell lung cancer, reflecting the breadth of pharmaceutical products...
- The Defense Logistics Agency awarded a $42,650.28 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 7, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tagrisso is a prescription oncology medication used in the treatment of certain lung cancers, and this award...
- The Defense Logistics Agency awarded a delivery order valued at $10,641.07 to AmerisourceBergen Drug Corp for the supply of Tagrisso 40 mg tablets (30-count units) on August 22, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Tagrisso is a targeted cancer therapy used in treating certain lung cancers,...
- The Defense Logistics Agency awarded a $12.44K delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Tagrisso 80 mg tablets, with performance at the contractor's Conshohocken, Pennsylvania facility. This non-competitive, firm fixed-price delivery order was awarded on January 5, 2026, with an ultimate completion date of January 27, 2026. Tagrisso (osimertinib) is a targeted cancer therapy used primarily in lung cancer treatment, reflecting the critical pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at approximately $128K to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units). This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by October 16, 2025. The contract was awarded on September 24, 2025, with performance occurring at the contractor's corporate headquarters in Conshohocken, Pennsylvania. Tagrisso (osimertinib) is a targeted...
- The Defense Logistics Agency awarded a delivery order valued at $42,650.28 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on September 12, 2025, with completion expected by October 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Tagrisso is an oncology medication used in the treatment of non-small cell lung cancer,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a contract ceiling value of $10,662.57. This firm fixed-price delivery order, which is expected to be completed by October 3, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Tagrisso is a prescription oncology medication used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tagrisso 80 mg tablets in a quantity of 30 units, with a contract ceiling value of $10,662.57. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is scheduled for completion by September 30, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Tagrisso 80 mg tablets (quantity: 30-count packages) with a ceiling value of $21,303.64. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for completion by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tagrisso is a prescription oncology medication used in...